NewsRx

Search our medical news database

Diagnostics

Innogenetics moves into human papillomavirus diagnostics

Published in Vaccine Weekly, October 4th, 2006

Innogenetics announced its entry into the field of human papillomavirus (HPV) diagnostic testing, in line with its diagnostics growth strategy.

The announcement coincides with the 23rd International Papillomavirus Congress and Clinical Workshop in Prague, Czech Republic, gathering specialists in the field of HPV diagnostics and therapeutics. Infection with HPV genotypes 16 and 18, amongst others, is strongly associated with the development of cervical cancer, the second most common cause of cancer-related deaths in women worldwide. These genotypes are also present in the recently developed HPV prophylactic vaccines and are all detectable with Innogenetics' HPV...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook